Haemonetics HAE Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's deferred tax assets?
- Haemonetics (HAE) reported deferred tax assets of $9.52M in Q1 2026.
- How has Haemonetics's deferred tax assets changed year-over-year?
- Haemonetics's deferred tax assets increased by 22.0% year-over-year, from $7.8M to $9.52M.
- What is the long-term trend for Haemonetics's deferred tax assets?
- Over 5 years (2021 to 2026), Haemonetics's deferred tax assets has grown at a 9.6% compound annual growth rate (CAGR), from $6.01M to $9.52M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.